Revvity Sites Globally
Select your location.
*e-commerce not available for this region.
Case Study
High-content analysis of drug-induced oligodendrocyte differentiation promoting remyelination in multiple sclerosis
One of the greatest challenges in multiple sclerosis (MS) therapy is the halting or reversal of the failure of remyelination in the brain in order to reverse disabilities in MS patients. This case study highlights the recent work of Dr. Paul Tesar and colleagues at the Case Western Reserve University School of Medicine, which could potentially lead to such novel treatments, as it aims to control the function of stem cells in the body and thereby to help the body repair itself.
For research use only. Not for use in diagnostic procedures.
To view the full content please answer a few questions
Download Resource
High-content analysis of drug-induced oligodendrocyte differentiation promoting remyelination in multiple sclerosis